NSAIDs and spinal manipulation did nothing to speed recovery. Most episodes of acute lower back pain will resolve spontaneously, and guideline-recommended treatment consists primarily of ...

The reasons behind lower back pain are diverse, and its origin can be acute or chronic. Here are the most common causes: Sprain or Muscle Strain: Acute injuries, such as sprains or muscle strains ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Astronauts commonly reported acute and chronic pain during and after spaceflight, particularly in the lumbar spine. During and after spaceflight, astronauts experience lower back pain (LBP), lumbar ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Researchers have uncovered how specific patterns in brain activity can predict an individual's sensitivity to pain, expanding opportunities for improved pain management strategies.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Opens in a new tab or window NSAIDs, ketamine, and mid- to high-potency opioids reduced acute pediatric pain, but effects were ... or were supported by low- or very low-certainty evidence, Olejnik ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...